Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Dec 03, 2018

New Pore and More

At a user meeting, Oxford Nanopore gave an update on what it has been working on.

Nov 09, 2018

Illumina's Proposed PacBio Acquisition Leaves Customers Cautiously Optimistic

Premium

Users expressed concern that Illumina would have an even tighter grip on the sequencing market but are optimistic that it would spur development of PacBio's technology.

Oct 18, 2018

Amgen Invests £50M in Oxford Nanopore

Privately owned Oxford Nanopore offers a range of tools and and instruments based on a proprietary nanopore-based DNA and RNA sequencing technology.

Oct 12, 2018

New Products Posted to GenomeWeb: Pacific Biosciences, Oxford Nanopore, Cellecta, More

Sep 13, 2018

Vertebrate Genomes Project Releases First Assemblies; Describes Challenges, Plans

Premium

The VGP released its first 15 high-quality reference genome assemblies today, which are part of the project's first phase to sequence 260 vertebrate genomes.

Jul 30, 2018

Predicted to Grow

The South China Morning Post reports that DNA testing kit makers are investing in China.

Jul 09, 2018

Grandomics Raises Nearly RMB 100M in Series B Financing

The Beijing-based firm said it will use the funding for research and development, to obtain additional intellectual property, and to pursue its strategic goals.

Jun 19, 2018

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Jun 14, 2018

Oxford Nanopore's Revenues Triple in 2017

The company had £13.8 million ($18.4 million) in revenues and a net loss of £56.6 million in 2017.

Jun 14, 2018

DNA Scaffolds Could Enable Construction of Custom Nanopores for Protein Sequencing

Premium

University of Oxford researchers used DNA scaffolds to build custom peptide nanopores that they said could make nanopore-based protein analysis more feasible.

Pages

The Scan

After Your Number

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Not Quite How It Works

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Research, But Not in Name

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

Science Finds Support for Gene Drives Depends on Species Targeted, Ability to Control Drive; More

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.

What's Popular?

In Oxford Nanopore

  1. Oxford Nanopore Responds in Court to Pacific Biosciences Allegations of Willful Infringement

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.